运动诱导的自改善运动症状 通过α-synuclein降解在帕金森病中的渐进性:一篇评论
Hanna Goenawan1, Shabrina Kiasati2, Nova Sylviana1
1Department of Biomedical Sciences, Faculty of Medicine, Universitas Padjadjaran, Bandung, Indonesia.
Neuropsychiatric disease and treatment
|May 31, 2023
概括
运动激活了自和髓,这是可能通过清除有毒蛋白质聚合物来延迟帕金森病 (PD) 运动症状进展的关键过程.
科学领域:
- 分子生物学分子生物学
- 神经科学是一个神经科学.
- 运动生理学 运动生理学
背景情况:
- 帕金森病 (PD) 的特点是有毒的α-synuclein聚合物的积累.
- 自和髓是维持神经元健康所必需的细胞降解过程.
- 了解运动对这些路径的分子影响对于PD治疗策略至关重要.
研究的目的:
- 审查运动诱导的自和共背后的分子机制.
- 探索这些运动诱导过程在延迟帕金森病运动症状进展中的潜力.
主要方法:
- 对相关科学文献进行系统审查.
- 对研究运动,自,髓和帕金森病的研究进行分析.
- 对包括AMPK-ULK1和PINK1/Parkin在内的分子通路的检查.
主要成果:
- 运动显然会诱导自和共.
- 通过运动激活自可能涉及AMPK-ULK1通路.
- 通过运动诱导髓可以通过PINK1/帕金和AMPK依赖的途径发生.
- 运动诱导的自可以减少有毒的α-synuclein聚合物的积累.
结论:
- 运动诱导的自和神经是帕金森病的有前途的治疗途径.
- 这些通过体力活动激活的细胞过程可以减轻PD运动缺陷的进展.
- 针对运动介导的自/髓可能为帕金森病管理提供一种新的策略.
更多相关视频
14:45Analyzing the Parkinson's Disease Mouse Model Induced by Adeno-associated Viral Vectors Encoding Human α-Synuclein
Published on: July 29, 2022
6.0K
06:07Author Spotlight: Establishing a New Fluorescence-Based Protocol for In Vivo Mitochondrial Morphology Analysis in Parkinson's Disease
Published on: June 23, 2023
1.6K
相关概念视频
Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
Lysosomal Hydrolases
Lysosomes are the site for the degradation of macromolecules and biological polymers released during membrane trafficking events such as secretory, endocytic, autophagic, and phagocytic pathways. The membrane-enclosed area of the lysosome, called the lumen, contains hydrolytic enzymes active in an acidic environment. These acid hydrolases are functional at a pH between 4.5 and 5 and are involved in cellular processes such as cell signaling, energy metabolism, restoration of the plasma membrane,...
Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
